BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34731728)

  • 1. Comparison of Features and Outcomes of Undifferentiated Pleomorphic Sarcoma of Bone and Soft Tissue.
    Gusho CA; Lee L; Guntin J; Blank AT
    J Surg Res; 2022 Feb; 270():313-320. PubMed ID: 34731728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
    J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.
    Vodanovich DA; Spelman T; May D; Slavin J; Choong PFM
    ANZ J Surg; 2019 Sep; 89(9):1045-1050. PubMed ID: 31364245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
    Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
    Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
    Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
    Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray study.
    Lahat G; Zhang P; Zhu QS; Torres K; Ghadimi M; Smith KD; Wang WL; Lazar AJ; Lev D
    Histopathology; 2011 Sep; 59(3):556-61. PubMed ID: 22034893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities -- an analysis of 140 patients.
    Lehnhardt M; Daigeler A; Homann HH; Schwaiberger V; Goertz O; Kuhnen C; Steinau HU
    Langenbecks Arch Surg; 2009 Mar; 394(2):313-20. PubMed ID: 18584203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
    Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
    Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive factors in undifferentiated pleomorphic sarcoma: A long-term study from a large tertiary care urban center.
    Gonzalez MR; Clunk MJ; Bedi ADS; Werenski JO; Lang JH; Karczewski D; Sodhi A; Lozano-Calderon SA
    J Surg Oncol; 2023 Aug; 128(2):322-331. PubMed ID: 37042427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
    Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
    Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
    Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
    Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
    Malik AT; Baek J; Alexander JH; Voskuil RT; Khan SN; Scharschmidt TJ
    J Surg Oncol; 2020 Jun; 121(7):1097-1103. PubMed ID: 32133661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal sarcomatosis due to undifferentiated pleomorphic sarcoma: A case report and review of the literature.
    Sogutcu N; Kavak S; Gumus S
    Indian J Pathol Microbiol; 2023; 66(2):356-359. PubMed ID: 37077083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.
    Lee K; Song JS; Kim JE; Kim W; Song SY; Lee MH; Chung HW; Cho KJ; Lee JS; Ahn JH
    Eur J Surg Oncol; 2020 Jul; 46(7):1287-1293. PubMed ID: 32127249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
    Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
    J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UNDIFFERENTIATED PLEOMORPHIC SARCOMA: PROGNOSTIC FACTORS IN 42 EXTREMITY CASES.
    Maçaneiro CH; Baptista AM; Camargo OP; Filippi RZ; Oliveira ET
    Acta Ortop Bras; 2023; 31(2):e265942. PubMed ID: 37151725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.
    Kamat NV; Million L; Yao DH; Donaldson SS; Mohler DG; van de Rijn M; Avedian RS; Kapp DS; Ganjoo KN
    Am J Clin Oncol; 2019 Feb; 42(2):166-171. PubMed ID: 30557163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Crago AM; Cardona K; Koseła-Paterczyk H; Rutkowski P
    Surg Oncol Clin N Am; 2022 Jul; 31(3):419-430. PubMed ID: 35715142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of undifferentiated pleomorphic sarcoma of the chest wall.
    Bennett C; Bharadwaj S; Arndt A; Chawla A
    Chin Clin Oncol; 2023 Dec; 12(6):66. PubMed ID: 38073309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.